Form 8.3 - Dechra Pharmaceuticals plc

Barclays PLC
08 January 2024
 

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR

MORE

Rule 8.3 of the Takeover Code (the "Code")

1.

KEY INFORMATION

(a)

Full name of discloser:

 

Barclays PLC.

(b)

Owner or controller of interest and short

 

 

positions disclosed, if different from 1(a):

(c)

Name of offeror/offeree in relation to whose

DECHRA PHARMACEUTICALS PLC

 

relevant securities this form relates:

(d)

If an exempt fund manager connected with an

 

 

offeror/offeree, state this and specify identity of

 

offeror/offeree:

(e)

Date position held/dealing undertaken:

05 Jan 2024

(f)

In addition to the company in 1(c) above, is the discloser making

NO

 

 

 

disclosures in respect of any other party to the offer?

 

 

2.

POSITIONS OF THE PERSON MAKING THE DISCLOSURE

(a)

Interests and short positions in the relevant securities of the offeror or offeree

 

 

to which the disclosure relates following the dealing(if any)

 

Class of relevant security:

1p ordinary

 

Interests

Short Positions

 

Number

(%)

Number

(%)

(1)

Relevant securities owned

 

 

 

 

 

and/or controlled:

 

 

7,378,429

6.48%

630,862

0.55%

(2)

Cash-settled derivatives:

 

 

 

 

 

and/or controlled:

 

 

631,329

0.55%

7,309,054

6.42%

(3)

Stock-settled derivatives (including options)

 

 

 

 

 

and agreements to purchase/sell:

 

 

0

0.00%

0

0.00%

 

 

 

 

 

 

 

 

 

TOTAL:

 

 

8,009,758

7.03%

7,939,916

6.97%

(b)

Rights to subscribe for new securities (including directors and other executive

 

 

options)

 

 

 

 

 

 

Class of relevant security in relation to

 

 

 

 

which subscription right exists

 

 

 

 

Details, including nature of the rights

 

 

 

 

concerned and relevant percentages:

 

 

 

 

3.

DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER

(a)

Purchases and sales

 

 

 

 

 

Class of relevant

Purchase/sale

Number of

Price per unit

security

 

securities

 

1p ordinary

Purchase

6,941

38.5780  GBP

1p ordinary

Purchase

6,719

38.5800  GBP

1p ordinary

Purchase

4,411

38.6000  GBP

1p ordinary

Purchase

2,000

38.5772  GBP

1p ordinary

Purchase

1,857

38.5797  GBP

1p ordinary

Purchase

726

38.5600  GBP

1p ordinary

Purchase

10

38.5648  GBP

1p ordinary

Purchase

3

38.5866  GBP

1p ordinary

Purchase

2

38.5950  GBP

1p ordinary

Sale

10,329

38.5799  GBP

1p ordinary

Sale

9,388

38.5800  GBP

1p ordinary

Sale

5,041

38.5798  GBP

1p ordinary

Sale

3,556

38.5793  GBP

1p ordinary

Sale

2,591

38.5658  GBP

1p ordinary

Sale

109

38.5900  GBP

1p ordinary

Sale

108

38.5811  GBP

1p ordinary

Sale

34

38.5952  GBP

 

 

 

 

 

 

 

 

(b)

Cash-settled derivative transactions

 

Class of

Product

Nature of dealing

Number of

Price per

relevant

description

 

reference

unit

security

 

 

securities

 

1p ordinary

SWAP

Closing Short

224

38.6000  GBP

1p ordinary

SWAP

Closing Short

560

38.5795  GBP

1p ordinary

SWAP

Closing Short

5,092

38.5963  GBP

1p ordinary

SWAP

Decreasing Long

388

38.5800  GBP

1p ordinary

SWAP

Decreasing Short

1

38.5800  GBP

1p ordinary

SWAP

Decreasing Short

34

38.5951  GBP

1p ordinary

SWAP

Increasing Long

3,607

38.5793  GBP

1p ordinary

SWAP

Increasing Short

2

38.5938  GBP

1p ordinary

SWAP

Increasing Short

3

38.5871  GBP

1p ordinary

SWAP

Increasing Short

4

38.6050  GBP

1p ordinary

SWAP

Increasing Short

10

38.5648  GBP

1p ordinary

CFD

Increasing Short

685

38.5628  GBP

1p ordinary

SWAP

Opening Long

3,985

38.5800  GBP

1p ordinary

SWAP

Opening Long

7,896

38.5752  GBP

 

 

 

 

 

 

 

 

(c)

Stock-settled derivative transactions (including options)

 

(i)

Writing, selling, purchasing or varying

 

Class

Product

Writing,

Number

Exercise

Type

Expiry

Option

of

description

purchasing,

of

price

 

date

money

relevant

 

selling,

securities

per unit

 

 

paid/

security

 

varying etc

to which

 

 

 

received

 

 

 

option

 

 

 

per unit

 

 

 

relates

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(ii)

Exercising

 

 

 

 

 

 

Class of relevant

Product description

Exercising/ exercised against

Number of

Exercise price per

security

 

 

securities

unit

 

 

 

 

 

 

 

 

 

 

 

 

 

(d)

Other dealings (including subscribing for new securities)

 

Class of relevant

Nature of Dealings

Details

Price per unit (if

security

 

 

applicable)

 

 

 

 

4.

OTHER INFORMATION

(a)

Indemnity and other dealings arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding,

 

 

formal or informal, relating to relevant securities which may be an inducement to deal

 

 

or refrain from dealing entered into by the exempt principal trader making the disclosure and any party

 

to the offer or any person acting in concert with a party to the offer:

 

 

 

NONE

(b)

Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between

 

 

the person making the disclosure and any other person relating to:

 

 

(i)  the voting rights of any relevant securities under any option; or

 

 

 

(ii) the voting rights of future acquisition or disposal of any relevant securities to which

 

 

any derivative is referenced:

 

 

 

 

 

 

NONE

(c)

Attachments

 

 

 

 

 

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

Date of disclosure:

08 Jan 2024

Contact name:

Large Holdings Regulatory Operations

Telephone number:

020 3134 7213

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings